Pharmaceutical Economics and Policy

27 та иш

Enhancing global access to cancer medicines
Javier Cortés, José Manuel Pérez-García, Antonio Llombart‐Cussac +13
Шарҳ мақолаEconomic and Financial Impacts of CancerCA A Cancer Journal for Clinicians20201 иқтибос
ABI
Shortages and price variability of essential cytotoxic medicines for treating children with cancers
Yehoda M. Martei, Kotoji Iwamoto, Ronald D. Barr +2
МақолаPharmaceutical Economics and PolicyBMJ Global Health20201 иқтибос
ABI
563 Long-term acceptance of nebivolol in idiopathic dilated cardiomyopathy patients
Т. А. Абдуллаев, Н. А. Курбанов, I. R. Bekbulatova +1
МақолаHeart Failure Treatment and ManagementEuropean Journal of Heart Failure Supplements20060 иқтибос
ABI
A Status Report on the Health Care Sector in France
N. Lalitha, Samira Guennif
МақолаPharmaceutical Economics and PolicyJournal of Health Management20080 иқтибос
ABI
The Politics and Strategy of Industry Self-Regulation: The Pharmaceutical Industry's Principles for Ethical Direct-to-Consumer Advertising as a Deceptive Blocking Strategy
Denis Arnold, James L. Oakley
МақолаPharmaceutical industry and healthcareJournal of Health Politics Policy and Law20130 иқтибос
ABI
P767Efficacy and safety of switching simvastatin intolerant patients with coronary artery disease to rosuvastatin treatment
Aleksandr B. Shek, Р. Д. Курбанов, G J Abdullaeva +3
МақолаLipoproteins and Cardiovascular HealthEuropean Heart Journal20170 иқтибос
ABI
PO432 Compliance With Drug Therapy In Relation to Acute Coronary Events (A Fragment of the Register RACSMI-Uz)
G. Nagaeva, S. Nagaev
МақолаPharmaceutical Economics and PolicyGlobal Heart20180 иқтибос
ABI
PO433 Compliance With Drug Therapy In Relation to Acute Coronary Events (A Fragment of the Register RACSMI-Uz)
G. Nagaeva, S. Nagaev
МақолаPharmaceutical Economics and PolicyGlobal Heart20180 иқтибос
ABI
Antimicrobial Medicines Consumption in Eastern Europeand Central Asia – An Updated Cross-National Study and Assessment of QuantitativeMetrics for Policy Action
Jane Robertson, Kotoji Iwamoto, Iris Hoxha +18
МақолаAntibiotic Use and ResistanceFrontiers in Pharmacology20190 иқтибос
ABI
PCN252 QUALITY EVALUATION OF PHARMACOECONOMIC STUDIES IN RUSSIAN CANCER RESEARCH: AN OUTSIDE VIEW
S. Djalalov, Dilfuza Djalalova, Murray Krahn +2
МақолаHealth Systems, Economic Evaluations, Quality of LifeValue in Health20190 иқтибос
ABI
O'zbekistonda farmasevtika sanoatining rivojlanishi
Sh. Yakubova
МақолаPharmaceutical Economics and PolicyОбщество и инновации20210 иқтибос
ABI
Pharmacoeconomics and the Patients’ Compliance as an Essential part of Successful therapy of iron Deficiency Anemia.
Khodjieva Gulirano Sayfullaevna
МақолаHealth Systems, Economic Evaluations, Quality of LifeIndonesian Journal of Innovation Studies20220 иқтибос
ABI
Sudden Spurt in Pediatric Patients with AKI in Uzbekistan: A Call for International Drug Quality Control and Pharmaceutical Legislation
Nodira Murtalibova, Sidharth Kumar Sethi, Rupesh Raina +2
МақолаPharmaceutical Quality and CounterfeitingKidney36020230 иқтибос
ABI
AVAILABILITY AND COSTS OF MEDICINES FOR THE TREATMENT OF TUBERCULOSIS
Batirova Barchinoy Tadjimukhammadovna
МақолаTuberculosis Research and EpidemiologyInternational Journal of Medical Sciences And Clinical Research20240 иқтибос
ABI
Content analysis of anticancer drugs of the pharmaceutical market of the republic of Uzbekistan
Шохиста Шарофиддин кизи Мелибоева, Мизроб Мавлонович Болтаев, Umida Narzulaeva
МақолаPharmaceutical Economics and PolicyBIO Web of Conferences20240 иқтибос
ABI
Fınancıal sustaınabılıty and rısk in antı-agıng startups
Mehmet Mustafa Besirikli
МақолаPharmaceutical Economics and PolicyJournal of Forensic Accounting Profession20240 иқтибос
ABI
Drug-drug interactions in clinical practice: a literature review and SWOT analysis
Valeriya O. Barysheva, О. S. Golikova, В. Г. Кудрина +1
Шарҳ мақолаPharmaceutical Practices and Patient OutcomesMedical Technologies Assessment and Choice20240 иқтибос
ABI
Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies
Homie Razavi, Imam Waked, Huma Qureshi +97
МақолаHepatitis C virus researchJournal of Hepatology20250 иқтибос
ABI
EXPERIMENTAL ESTIMATION OF THE EFFICIENCY OF NEW POLICY IN THE PHARMACEUTICAL INDUSTRY
Sokhibmalik Khomidov
МақолаPharmaceutical Economics and PolicyЭкономика и предпринимательство20250 иқтибос
ABI
The Range of Medicines in The City of Samarkand: A Marketing Analysis
Makhmudova Maftuna Mehrojovna, Rayimqulova Ch.A.
МақолаEducational Management and QualityEuropean International Journal of Multidisciplinary Research and Management Studies20250 иқтибос
ABI
Blood-pressure and cholesterol lowering therapy with polypill and separate drug, their comparative effectiveness in persons with hypertension and dyslipidemia
Shakhlo Fayzullaeva, Г А Хамидуллаева
МақолаMedication Adherence and ComplianceAtherosclerosis20250 иқтибос
ABI
Validation of Kazakh and Russian Generic Drug Questionnaire
Zhandulla Nakipov, U. N. Musaev, Indira Smagylova +7
МақолаPharmaceutical Economics and PolicyMedical Journal of the Islamic Republic of Iran20250 иқтибос
ABI
Comparative Analysis of the Efficacy of a Polypill and a Free Combination of Antihypertensive Drugs and Statins in the Context of an Individualized Treatment Strategy
Shakhlo S. Fayzullaeva, Gulnoz A. Khamidullaeva, Guzal Zh. Abdullaeva +2
МақолаPharmaceutical Economics and PolicyInternational Journal of Biomedicine20250 иқтибос
ABI
STAGES OF DEVELOPMENT OF NEW MEDICINAL PRODUCTS
A.K. SADANOV, B.B. BAIMAKHANOVA, Z.Zh. TURLYBAYEVA +2
МақолаPharmaceutical Quality and CounterfeitingМИКРОБИОЛОГИЯ ЖӘНЕ ВИРУСОЛОГИЯ20250 иқтибос
ABI
Rare diseases as a global priority: the CIS Orphan Forum and the path toward collaboration with BRICS
Nuriya Z. Musina, Ahmed Al Saidi, Ayman W. El-Hattab +27
МақолаGenomics and Rare DiseasesThe BRICS Health Journal20260 иқтибос
ABI